After 1 month of treatment in pernicious anemia patients, the once weekly dosing of 500 mcg B12 intranasal gel resulted in a statistically significant increase in B12 levels when compared to a once monthly 100 mcg IM dose
This section provides actionable guidance for implementing an AHK-Cu protocol
While human longevity data is still emerging, the mechanistic basis for anti-aging effects is well-established
Researchers frequently evaluate MOTS-C 10MG / 5-Amino 1MQ 10MG Research Blend within controlled environments where consistency, documentation, and standardized procedures remain important components of the scientific process
Protocol Quick-Reference PRECLINICAL ONLY: NNMT inhibition research compound Dosing Amount No established human dose (mouse: ~34 mg/kg/day SC) Frequency No established human frequency Duration No established human duration Administration Route Oral Schedule N/A (preclinical compound) Timing NO HUMAN DOSING DATA EXISTS
Approximately 900 adult participants were enrolled across six randomized, double-blind, placebo-controlled clinical trials conducted between 2001 and 2006